These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7308253)

  • 41. BCG treatment of transplanted rat tumours of spontaneous origin.
    Pimm MV; Cook AJ; Hopper DG; Dickinson AM; Baldwin RW
    Int J Cancer; 1978 Oct; 22(4):426-32. PubMed ID: 700898
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BCG as an adjunct to radiotherapy: a mouse model.
    Kennedy JC; Novak T
    Int J Radiat Oncol Biol Phys; 1977; 2(7-8):685-91. PubMed ID: 893172
    [No Abstract]   [Full Text] [Related]  

  • 43. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
    Vaage J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proceedings: The effect of Bacille Calmette-Guérin (BCG) and Corynebacterium parvum on the development of spontaneous mouse mammary carcinoma.
    Simpson JS; Clark AW
    Br J Surg; 1976 Feb; 63(2):152-3. PubMed ID: 766891
    [No Abstract]   [Full Text] [Related]  

  • 45. Combination chemo-immunotherapy with adriamycin in experimental tumor systems.
    Tagliabue A; Polentarutti N; Vecchi A; Mantovani A; Spreafico F
    Eur J Cancer (1965); 1977 Jul; 13(7):657-65. PubMed ID: 598392
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunological investigation and immunotherapy in patients operated on for breast carcinoma.
    Reynier J; Villet R; Bazin JC; Bizzini B; Gandrille C; Guettier C; Henocq E; Hollmann K; Mogenet M; Pompidou A; Santus JP; Verley JM
    Int Surg; 1982; 67(1):17-24. PubMed ID: 7095998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BCG therapy given as an adjuvant to surgery: prevention of death from metastases from mammary adenocarcinoma in rats.
    Sparks FC; O'Connell TX; Lee YT; Breeding JH
    J Natl Cancer Inst; 1974 Dec; 53(6):1825-6. PubMed ID: 4474413
    [No Abstract]   [Full Text] [Related]  

  • 48. Various modalities of local administration of bacterial immunostimulants in transplantable rat tumours and in primitive methylcholanthrene mouse tumours.
    Goldberg N; Salomon JC
    Dev Biol Stand; 1977 Apr 13-15; 38():373-8. PubMed ID: 344100
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunological adjuvants in cancer immunotherapy.
    Baldwin RW
    Dev Biol Stand; 1977 Apr 13-15; 38():3-12. PubMed ID: 344097
    [No Abstract]   [Full Text] [Related]  

  • 50. Rejection of tumors and metastases in Fischer 344 rats following intratumor administration of killed Corynebacterium parvum.
    Likhite VV
    Int J Cancer; 1974 Nov; 14(5):684-90. PubMed ID: 4459281
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparative aspects of cancer immunotherapy: immunologic methods used for treatment of spontaneous cancer in animals.
    Theilen GH; Hills D
    J Am Vet Med Assoc; 1982 Nov; 181(10):1134-41. PubMed ID: 6757216
    [No Abstract]   [Full Text] [Related]  

  • 52. [Treatment of solid tumours by intratumoral injection of immunostimulants].
    Salomon JC; Lynch N
    Ann Immunol (Paris); 1977; 128(1-2):125-7. PubMed ID: 322574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of rat fibrosarcoma by radiotherapy plus immune adjuvant.
    Moroson H; Schechter M
    Biomedicine; 1976 May; 25(3):97-100. PubMed ID: 949523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methanol extraction residue of BCG in the treatment of transplanted rat tumours.
    Hopper DG; Pimm MV; Baldwin RW
    Br J Cancer; 1975 Feb; 31(2):176-81. PubMed ID: 169861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of treatment with Corynebacterium parvum on the development and growth of experimental hematogenic metastases of schwannoma in the rat.
    Bash JA; Mandybur TI; Ritschel WA
    Acta Neuropathol; 1985; 68(1):22-6. PubMed ID: 3876679
    [TBL] [Abstract][Full Text] [Related]  

  • 56. C. parvum treatment of transplanted rat tumours of spontaneous origin.
    Willmott N; Pimm MV; Baldwin RW
    Int J Cancer; 1979 Sep; 24(3):323-8. PubMed ID: 385514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intra-lesional injection of immunostimulants in bilateral rat tumors.
    Salomon JC; Galinha A; Lascaux V; Prin J; Puvion F; Lynch N
    Int J Cancer; 1976 Sep; 18(3):379-91. PubMed ID: 955748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of nonspecific immune stimulation with Corynebacterium parvum and polidin on the Ehrlich ascites tumor growth.
    Todoruţiu C; Rişcă R; Daicoviciu D; Mulea R
    Morphol Embryol (Bucur); 1982; 28(1):77-83. PubMed ID: 6461826
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Editorial: Immunological control of cancer.
    Lancet; 1975 Mar; 1(7905):502-3. PubMed ID: 46965
    [No Abstract]   [Full Text] [Related]  

  • 60. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. V. Comparison of the effects of tilorone hydrochloride, levamisole, methanol-soluble fraction of Mycobacterium butyricum, BCG, and a nonviable aqueous ether extract of Brucella abortus preparation in treatment of mice with tumors.
    Fisher B; Linta J; Hanlon J; Saffer E
    J Natl Cancer Inst; 1978 Feb; 60(2):391-9. PubMed ID: 413929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.